Our Tau Tales from Normal to Pathological Behavior.

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Tau protein is crucial for microtubule assembly.
• Hyperphosphorylated tau (P-tau) forms aggregates in Alzheimer's disease (AD).
• Abnormal tau disrupts neuronal function and microtubule stability.

Purpose of the Study:

• To characterize the toxic mechanisms of hyperphosphorylated tau.
• To identify key phosphorylation sites and mutations inducing pathological tau.
• To investigate the cellular and animal model consequences of pathological tau.

Main Methods:

• Biochemical analysis of AD P-tau.
• Use of phospho-mimetics to create pathological tau (PH-Tau).
• Cellular expression of PH-Tau and assessment of its effects.
• In vivo studies in animal models expressing PH-Tau.

Main Results:

• AD P-tau inhibits microtubule assembly and disrupts existing microtubules.
• Specific phosphorylation sites (199, 212, 231, 262) and mutations (R406W) induce toxic tau.
• PH-Tau expression causes microtubule disruption, altered localization, and cellular toxicity.
• Animal models show PH-Tau induces cognitive decline via synaptic dysfunction or neuronal death.

Conclusions:

• Hyperphosphorylated tau is a key driver of neurodegeneration in AD.
• Pathological tau exhibits toxic gain-of-function, disrupting cellular homeostasis.
• PH-Tau recapitulates key features of AD tau pathology in vitro and in vivo.
• Understanding tau pathology mechanisms is critical for developing AD therapies.